203 



that sort of need. You tell us this all is a coincidence and we will 

 inquire further about this. 



Mr. Waxman. Mr. Wyden, your time has expired, but I want to 

 say to you, Mr. Sandefur, before I recognize the next member in 

 line, is you are the chief executive officer of this company. You've 

 given these documents. You've had weeks to prepare. In fact, we 

 even postponed the hearing to give you more time to prepare. 



Why is it that you would come here and not know about the sci- 

 entists' research or the recommendations by the scientists and mar- 

 keting people for a higher nicotine cigarette to satisfy this so-called 

 inner need and act as if you had nothing to do with it? That's a 

 question that is in my mind and it is very perplexing. 



Mr. Bell. I would like to answer that. 



Mr. Waxman. I addressed it to Mr. Sandefur. He is the CEO. 



Mr. Bell. I understand that. I'm his lawyer. You are treating 

 him unfairly. To be fair 



Mr. Waxman. Mr. Bell, if you want to consult with your client, 

 I will give you an opportunity to do it. 



Mr. Bell. I don't need to consult with him. I'm hearing how he 

 has been treated. I heard your statement and I also heard Mr. Wy- 

 den's statement. Inferring that he is in some way not telling the 

 truth, you say he's not — 



Mr. Waxman. I did not say he was not telling the truth. I'm say- 

 ing it is hard to believe he doesn't know about the documents that 

 he submitted to us when he's the chief executive officer of the cor- 

 poration. 



He knew about this hearing. He knew the inquiry was about nic- 

 otine. He knew that his scientists had been working for decades on 

 this research and then this particular Project Wheat was based on 

 a marketing strategy based on the science which was implemented 

 by the company. It's hard to believe he doesn't know about it. 



Mr. Bell. I told Mr. — this witness to prepare himself on any- 

 thing that happened on his watch. This happened before he came 

 to work for the company. We have produced almost 7,000 pages of 

 documents. That's very unreasonable to say that he should have 

 studied all those documents and be prepared here today. That's 



Mr. Waxman. He is the chief executive officer of the corporation. 

 He's responsible for what the corporation has been doing and is 

 doing today and he should be the one to know the strategies, par- 

 ticularly as a marketing expert, why they have undertaken what 

 they have done in terms of the nicotine content of the cigarettes. 



I don't think we are treating him unfairly and I will leave that 

 as something we'll return to later. 



I think it is Mr. Greenwood's turn for questioning. 



Mr. Greenwood. Thank you, Mr. Chairman. I would like to yield 

 30 seconds to Mr. McMillan. 



Mr. McMillan. Real briefly, if the chairman will permit, I don't 

 think that Mr. Sandefur should be held to a standard that's dif- 

 ferent than we held Dr. Kessler on Tuesday, who is a scientist, I 

 think, and came prepared to deliver supposedly informed testi- 

 mony. Yet he couldn't tell us in a chart that he presented whether 

 the information referred to filter tip cigarettes or not. Nor could he 

 give us any evidence that in the three brands of cigarettes he pre- 



